Tranexamic Acid in Surgery of Advanced Ovarian Cancer
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if a standardized single dose tranexamic acid given
intravenously immediately preoperatively reduces the perioperative bleeding volume and
reduces the need of blood transfusion in women undergoing surgery for advanced ovarian
cancer.